Latest News

Platinum-Based Chemo for Bladder Cancer Linked With Increased Thromboembolism Risk

Platinum-Based Chemo for Bladder Cancer Linked With Increased Thromboembolism Risk

Patients receiving platinum-based chemotherapy were at higher risk of developing thromboembolism.

Immune Response to Chemo Improves PFS in Colorectal Cancer Liver Metastases

Immune Response to Chemo Improves PFS in Colorectal Cancer Liver Metastases

In colorectal cancer (CRC) liver metastases, neoadjuvant FOLFOX chemotherapy positively influenced local immune response.

African American Men With PCa Produce Less PSA Despite Larger Prostates

African American Men With PCa Produce Less PSA Despite Larger Prostates

African Americans (AAs) with prostate cancer who have a Gleason score of 3+3=6 produce less prostate-specific antigen.

Imetelstat Active in Myelofibrosis, But May Cause Myelosuppression

Imetelstat Active in Myelofibrosis, But May Cause Myelosuppression

Imetelstat was active in patients with myelofibrosis, but had the potential to cause clinically significant myelosuppression.

Lymphadenectomy Extent During Esophageal Cancer Surgery May Not Impact Survival

Lymphadenectomy Extent During Esophageal Cancer Surgery May Not Impact Survival

The extent of lymphadenectomy during surgery for esophageal cancer might not influence 5-year all-cause or disease-specific survival.

Risk for SNL Positivity Lower in Melanoma with Histologic Regression

Risk for SNL Positivity Lower in Melanoma with Histologic Regression

Risk of sentinel lymph node (SLN) positivity was significantly lower in patients with melanoma with histologic regression.

Targeted Therapy Based on Tumor Molecular Profiling May Not Improve Survival

Targeted Therapy Based on Tumor Molecular Profiling May Not Improve Survival

The use of molecularly targeted agents outside of their indications did not improve progression-free survival in heavily pretreated cancer.

Adding Glitazone to Chemotherapy May Help Treat Chronic Myeloid Leukemia

Adding Glitazone to Chemotherapy May Help Treat Chronic Myeloid Leukemia

Patients with chronic myeloid leukemia who received a glitazone along with imatinib remained disease-free for up to five years.

In First Personalized T-cell Trial, Long-Term Remissions for Chronic Leukemia

In First Personalized T-cell Trial, Long-Term Remissions for Chronic Leukemia

An experimental therapy for chronic lymphocytic leukemia that uses a patient's own T cells may cure patients and prolong survival.

More Male Breast Cancer Patients Opt to Have Both Breasts Removed

More Male Breast Cancer Patients Opt to Have Both Breasts Removed

There has been an increase in the number of American men with cancer in one breast who have surgery to remove their cancer-free breast.

Mushroom Powder May Reduce PSA Levels in Prostate Cancer

Mushroom Powder May Reduce PSA Levels in Prostate Cancer

For biochemically recurrent prostate cancer, treatment with white button mushroom (WBM) powder may reduce prostate-specific antigen (PSA).

FDA Approves Varubi for Chemo-Induced Nausea and Vomiting

FDA Approves Varubi for Chemo-Induced Nausea and Vomiting

The FDA has approved rolapitant (Varubi) in combination with other antiemetic agents for the prevention of delayed nausea and vomiting.

Temozolomide Should be Considered for Recurrent Ependymoma

Temozolomide Should be Considered for Recurrent Ependymoma

Temozolomide should be considered as a possible first-line treatment for adults with intracranial ependymoma after failure of surgery and radiotherapy.

Statin Use May Lower Risk for Pancreatic Cancer

Statin Use May Lower Risk for Pancreatic Cancer

Statin use may be associated with a decreased risk of pancreatic cancer in patients with type 2 diabetes.

EMC92-ISS Superior to Other Current Markers in Risk Classification for Myeloma Survival

EMC92-ISS Superior to Other Current Markers in Risk Classification for Myeloma Survival

The EMC92-International Staging System (ISS) is a robust novel prognostic tool compared with current markers.

Genomic Sequencing May Benefit Some Childhood Cancer Patients

Genomic Sequencing May Benefit Some Childhood Cancer Patients

For some pediatric cancer patients with relapsed or refractory cancer, extensive genetic analysis can open up new options.

Adjuvant Erlotinib Fails to Prolong Disease-Free Survival in EGFR-Expressing Lung Cancer

Adjuvant Erlotinib Fails to Prolong Disease-Free Survival in EGFR-Expressing Lung Cancer

Adjuvant erlotinib did not prolong-disease-free survival in patients with EGFR-expressing non-small cell lung cancer (NSCLC).

FOLFOXIRI Plus Bevacizumab Feasible for Some with Colorectal Cancer

FOLFOXIRI Plus Bevacizumab Feasible for Some with Colorectal Cancer

Fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) plus bevacizumab is a feasible treatment for some with metastatic colorectal cancer (mCRC).

Rates for Palliative Care Consultation Low Regardless of Race, Ethnicity

Rates for Palliative Care Consultation Low Regardless of Race, Ethnicity

Rates of inpatient palliative care consultation remain low and occur close to death irrespective of race/ethnicity.

Sonography, MRI Comparable for Cervical Cancer Staging

Sonography, MRI Comparable for Cervical Cancer Staging

Transvaginal sonography (TVS) is comparable to magnetic resonance imaging (MRI) for diagnosing and staging local cervical cancer.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs